CHRS Free Cash Flow Growth
Coherus Oncology Inc · Free Cash Flow Growth
CHRS Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-130.40%period ending
CHRS TTM Free Cash Flow YoY % (-277.91% → -130.40%)
Year-over-year change
High-resolution chart · PNG
CHRS free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| -130.4016% | |
| -34,214.6% | |
| -577.6566% | |
| -45.4216% | |
| -94.9542% | |
| 100.3267% | |
| 88.3313% | |
| 76.3502% | |
| 77.8793% | |
| 40.5362% | |
| 27.9619% | |
| -33.8548% | |
| -69.397% | |
| -172.0707% | |
| -527.9874% | |
| -523.6781% | |
| -285.7148% | |
| -169.3357% | |
| -126.3562% | |
| -64.9862% | |
| -44.602% | |
| 42.8039% | |
| 453.7029% | |
| 444.2151% | |
| 203.8171% | |
| 152.0092% | |
| 116.5774% | |
| 73.0775% | |
| 4.8248% | |
| -12.3212% | |
| 21.8707% | |
| 46.281% | |
| 49.8764% | |
| 36.0019% | |
| 20.9222% | |
| -61.2887% | |
| -73.3303% | |
| -61.501% | |
| -126.939% | |
| -8.1736% | |
| -70.9682% | |
| -109.2165% | |
| -326.3295% | |
| -1,384.6485% | |
| -344.2957% | |
| -305.7563% | |
| -277.9136% |